Analysis of the haptoglobin binding region on the apolipoprotein A-I-derived P2a peptide

Journal of Peptide Science

Volumn 19, Issue 4, 2013, Pages 220-226

  Spagnuolo, Maria Stefania ^a   Di Stasi, Rossella ^b   De Rosa, Lucia ^b   Maresca, Bernadetta ^c   Cigliano, Luisa ^c   D'Andrea, Luca D ^b  

^a CNR   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ApoA I; Haptoglobin; HDL; Helix conformation; LCAT

Indexed keywords

APOLIPOPROTEIN 141 161; APOLIPOPROTEIN 144 164; APOLIPOPROTEIN 146; APOLIPOPROTEIN 146 164; APOLIPOPROTEIN 147; APOLIPOPROTEIN 149; APOLIPOPROTEIN 150; APOLIPOPROTEIN 151; APOLIPOPROTEIN 153; APOLIPOPROTEIN 155; APOLIPOPROTEIN 157; APOLIPOPROTEIN 160; APOLIPOPROTEIN 162; APOLIPOPROTEIN A1; CARDIOVASCULAR AGENT; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN P 2A; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; APOLIPOPROTEIN A-I; BINDING SITES; CHOLESTEROL; FEMALE; HAPTOGLOBINS; HUMANS; MALE; PEPTIDES; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 84875594325     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.2487     Document Type: Article

References (33)

1. Sorci-Thomas MG, Thomas MJ. The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc. Med. 2002; 12: 121-128.
2. Davidson WS, Thompson TB. The structure of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 2007; 282: 22249-22253.
3. Thomas MJ, Bhat S, Sorci-Thomas MG. Three-dimensional models of HDL apoA-I: implications for its assembly and function. J. Lipid Res. 2008; 49: 1875-1883.
4. Wu Z, Gogonea V, Lee X, Wagner MA, Li XM, Huang Y, Undurti A, May RP, Haertlein M, Moulin M, Gutsche I, Zaccai G, Didonato JA and Hazen SL. Double superhelix model of high density lipoprotein. J. Biol. Chem. 2009; 284: 36605-36619.
5. Mei X, Atkinson D. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J. Biol. Chem. 2011; 286: 38570-38582.
6. Huang R, Silva RA, Jerome WG, Kontush A, Chapman MJ, Curtiss LK, Hodges TJ, Davidson WS. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 2011; 18: 416-422.
7. Wu Z, Gogonea V, Lee X, May RP, Pipich V, Wagner MA, Undurti A, Tallant TC, Baleanu-Gogonea C, Charlton F, Ioffe A, Di Donato JA, Rye KA, Hazen SL. The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering. J. Biol. Chem. 2011; 286: 12495-124508.
8. Sevugan Chetty P, Mayne L, Kan ZY, Lund-Katz S, Englander SW, Phillips MC Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 2012; 109: 11687-11692.
9. Balestrieri M, Cigliano L, De Simone ML, Dale B, Abrescia P. Haptoglobin inhibits lecithin-cholesterol-acyltrasferase in human ovarian follicular fluid. Mol. Reprod. Dev. 2001; 59: 186-191.
10. Spagnuolo MS, Cigliano L, Abrescia, P. The binding of haptoglobin to apolipoprotein A-I: influence of hemoglobin and concanavalin A. Biol. Chem. 2003; 384: 1593-1596.
11. Giblett ER. The haptoglobin system. Ser. Haematol. 1968; 1: 3-20.
12. Nagel RL, Gibson QH. The binding of Hemoglobin to Haptoglobin and its relation to subunit dissociation of Hemoglobin. J. Biol. Chem. 1971, 246: 69-73.
13. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 1996; 42: 1589-1600.
14. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK Identification of the haemoglobin scavenger receptor. Nature 2001; 409: 198-201.
15. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim. Biophys. Acta 1987; 917: 219-223.
16. Alayash AI. Redox biology of blood. Antioxid. Redox Signal. 2004; 6: 941-949.
17. Salvatore A, Cigliano L, Bucci EM, Corpillo D, Velasco S, Carlucci A, Pedone C, Abrescia P. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry 2007; 46: 1158-1168.
18. Cigliano L, Pugliese CR, Spagnuolo MS, Palumbo R, Abrescia P. Haptoglobin binds the antiatherogenic protein apolipoprotein E - impairment of apolipoprotein E stimulation of both lecithin:cholesterol acyltransferase activity and cholesterol uptake by hepatocytes. FEBS J. 2009; 276: 6158-6171.
19. Braeckman L, De Bacquer D, Delanghe J, Claeys L, De Backer G. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 1999; 143: 383-388.
20. De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H, Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 2001; 157: 161-166.
21. Matuszek MA, Aristoteli LP, Bannon PG, Hendel PN, Hughes CF, Jessup W, Dean RT, Kritharides L. Haptoglobin elutes from human atherosclerotic coronary arteries--a potential marker of arterial pathology. Atherosclerosis 2003; 168: 389-396.
22. Sorci-Thomas MG, Curtiss L, Parks JS, Thomas MJ, Kearns MW, Landrum M. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin: cholesterol acyltransferase activation. J. Biol. Chem. 1998; 273: 11776-11782.
23. Spagnuolo MS, Cigliano L, D'Andrea LD, Pedone C, Abrescia P Assignment of the binding site for haptoglobin on apolipoprotein A-I. J. Biol. Chem. 2005; 280: 1193-1198.
24. Bucci M, Cigliano L, Vellecco V, D'Andrea LD, Ziaco B, Rossi A, Sautebin L, Carlucci A, Abrescia P, Pedone C, Ianaro A, Cirino G. Apolipoprotein A-I (ApoA-I) mimetic peptide P2a by restoring cholesterol esterification unmasks ApoA-I anti-inflammatory endogenous activity in vivo. J. Pharmacol. Exp. Ther. 2012; 340: 716-722.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-254.
26. Cigliano L, Spagnuolo MS, Abrescia P Quantitative variations of the isoforms in haptoglobin 1-2 and 2-2 individual phenotypes. Arch. Biochem. Biophys. 2003; 416: 227-237.
27. Cigliano L, D'Andrea LD, Maresca B, Serino M, Carlucci A, Salvatore A, Spagnuolo MS, Scigliuolo G, Pedone C, Abrescia P. Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin. Biol. Chem. 2008; 389: 1421-1426.
28. Porta A, Cassano E, Balestrieri M, Bianco M, Picone R, De Stefano C, Abrescia P. Haptoglobin transport into human ovarian follicles and its binding to apolipoprotein A-I. Zygote 1999; 7: 67-77.
29. Chen C-H, Albers JJ. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J. Lipid Res. 1982; 23: 680-691.
30. DeGrado WF, Summa CM, Pavone V, Nastri F, Lombardi A. De novo design and structural characterization of proteins and metalloproteins. Annu. Rev. Biochem. 1999; 68: 779-819.
31. Luo P, Baldwin RL. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. Biochemistry 1997; 36: 8413-8421.
32. Rohl CA, Chakrabartty A, Baldwin RL Helix propagation and N-cap propensities of the amino acids measured in alanine-based peptides in 40 volume percent trifluoroethanol. Protein Sci. 1996; 5: 2623-2637.
33. Vuilleumier S, Mutter M. Synthetic peptide and template-assembled synthetic protein models of the hen egg white lysozyme 87-97 helix: importance of a protein-like framework for conformational stability in a short peptide sequence. Biopolymers 1993; 33: 389-400.